backJoin us for the ninth CLE webinar in our Fundamentals of EU Pharmaceutical Law series. We will examine the requirements for interacting with HCPs/HCOs/POs as well as the anti-kickback and transparency frameworks applicable to pharmaceutical companies operating in the EU and the UK.
This session will provide an in-depth analysis of the obligations related to interactions with healthcare professionals, healthcare organizations, patient organizations and patients. We will address both statutory requirements and industry codes of practice, with a particular emphasis on national variations — focusing on France, which has one of the most stringent regulatory environments in this area.
Topics will include the rules governing gifts, hospitality, financial incentives and limitations under national laws. The webinar will also cover reporting obligations, procedures for notifications or prior approvals and practical guidance on submission processes and deadlines.
Enforcement trends and the future direction of transparency and anti-kickback legislation will also be discussed, offering participants a well-rounded understanding of the current and emerging compliance landscape.
For questions or for information about registration, contact Christine Lieber.